−0.2479USD
−11.51 MUSD
911.00 KUSD
59.49 M
About IGC Pharma, Inc.
Sector
Industry
CEO
Ram Mukunda
Website
Headquarters
Potomac
Employees (FY)
61
Founded
2005
ISIN
US45408X3089
FIGI
BBG000NSSLY8
IGC Pharma, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment is involved in the rental of heavy construction equipment, execution of construction contracts, and purchase and resale of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IGC is 0.4392 USD — it has decreased by 0.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange IGC Pharma, Inc. stocks are traded under the ticker IGC.
IGC Pharma, Inc. is going to release the next earnings report on Jun 20, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for IGC Pharma, Inc. has a max estimate of 3.2500 USD and a min estimate of 3.2500 USD.
Yes, you can track IGC Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, IGC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IGC Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 61.00 employees. See our rating of the largest employees — is IGC Pharma, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IGC Pharma, Inc. EBITDA is −11.04 M USD, and current EBITDA margin is −1.20 K%. See more stats in IGC Pharma, Inc. financial statements.